Cheng-Kang Peng

Jinan University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index105citations4works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer therapeutics and mechanisms(2), Bioactive Compounds and Antitumor Agents(2), Synthesis and bioactivity of alkaloids(2), Tuberculosis Research and Epidemiology(1), Computational Drug Discovery Methods(1)

Publications4 total

New molecular insights into the tyrosyl-tRNA synthase inhibitors: CoMFA, CoMSIA analyses and molecular docking studies
Scientific Reports·2017· 15 citedOpen Access
Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity
Journal of Medicinal Chemistry·2017· 52 cited
Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors
European Journal of Medicinal Chemistry·2016· 21 cited
Novel securinine derivatives as topoisomerase I based antitumor agents
European Journal of Medicinal Chemistry·2016· 17 cited

Frequent Co-authors

Wei‐Min Chen(4), Yiqun Chang(3), Pinghua Sun(3), Wen Hou(2), Hui Lin(2), Jing Lin(2), Lijuan Deng(1), Long-Hai Wang(1), Yibin Li(1), Maohua Huang(1), Minfeng Chen(1), Xueping Lei(1), Ming Qi(1), Yun Cen(1), Wen‐Cai Ye(1), Dongmei Zhang(1), Ting Zeng(1), Xingjun Xu(1), K S Lu(1), Zhenya Wang(1)